The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment
Open accessAbstract
Aspergillus fumigatus remains the most common species in all pulmonary syndromes, followed by Aspergillus flavus which is a common cause of allergic rhinosinusitis, postoperative aspergillosis and fungal keratitis. The manifestations of Aspergillus infections include invasive aspergillosis, chronic pulmonary aspergillosis and bronchitis. Allergic manifestations of inhaled Aspergillus include allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. Triazoles are the mainstay of therapy against Aspergillus infections for treatment and prophylaxis. Lately, increased azole resistance in A. fumigatus has become a significant challenge in effective management of aspergillosis. Earlier studies have brought to light the contribution of non-cyp51 mutations along with alterations in cyp51A gene resulting in azole-resistant phenotypes of A. fumigatus. This review highlights the magnitude of azole-resistant aspergillosis and resistance mechanisms implicated in the development of azole-resistant A. fumigatus and address the therapeutic options available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Denning, D. W., Cadranel, J., Beigelman-Aubry, C., Ader, F., Chakrabarti, A., Blot, S., Ullmann, A. J., Dimopoulos, G., & Lange, C. (2016) · European Respiratory Journal · doi:10.1183/13993003.00583-2015 · Cited by 1,030
The clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050219 · Cited by 727
Verweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561
Self-citationItraconazole resistance in Aspergillus fumigatus
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 508
Denning, D. W., Pleuvry, A., & Cole, D. C. (2013) · Medical Mycology · doi:10.3109/13693786.2012.738312 · Cited by 495
Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490
Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009
van der Linden, J. W. M., Snelders, E., Kampinga, G. A., Rijnders, B. J. A., Mattsson, E., Debets-Ossenkopp, Y. J., Kuijper, E. J., Van Tiel, F. H., Melchers, W. J. G., & Verweij, P. E. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110226 · Cited by 446
Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus
Snelders, E., Camps, S. M. T., Karawajczyk, A., Schaftenaar, G., Kema, G. H. J., van der Lee, H. A., Klaassen, C. H., Melchers, W. J. G., & Verweij, P. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031801 · Cited by 427
Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010
Bitar, D., Lortholary, O., Le Strat, Y., Nicolau, J., Coignard, B., Tattevin, P., Che, D., & Dromer, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.140087 · Cited by 426
Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
Snelders, E., Huis in 't Veld, R. A. G., Rijs, A. J. M. M., Kema, G. H. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00231-09 · Cited by 423
Chowdhary, A., Kathuria, S., Xu, J., & Meis, J. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003633 · Cited by 380
Self-citationMultiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus
van der Linden, J. W. M., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., Chryssanthou, E., Mellado, E., Kidd, S. E., Tortorano, A. M., et al. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2106.140717 · Cited by 371
Willger, S. D., Puttikamonkul, S., Kim, K.-H., Burritt, J. B., Grahl, N., Metzler, L. J., Barbuch, R., Bard, M., Lawrence, C. B., & Cramer, R. A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000200 · Cited by 345
van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit320 · Cited by 342
Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent
Miceli, M. H., & Kauffman, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ571 · Cited by 338
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
Bueid, A., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., & Denning, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq279 · Cited by 338
Verweij, P. E., Ananda-Rajah, M., Andes, D., Arendrup, M. C., Brüggemann, R. J., Chowdhary, A., Cornely, O. A., Denning, D. W., Groll, A. H., Izumikawa, K., et al. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.001 · Cited by 330
Self-citationClinical implications of globally emerging azole resistance in Aspergillus fumigatus
Meis, J. F., Chowdhary, A., Rhodes, J. L., Fisher, M. C., & Verweij, P. E. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0460 · Cited by 308
Self-citationDiaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
Alastruey-Izquierdo, A., Mellado, E., Peláez, T., Pemán, J., Zapico, S., Alvarez, M., Rodríguez-Tudela, J. L., Cuenca-Estrella, M., & FILPOP Study Group (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00383-13 · Cited by 276
Lockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J., & Balajee, S. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-11 · Cited by 231
Camps, S. M. T., van der Linden, J. W. M., Li, Y., Kuijper, E. J., van Dissel, J. T., Verweij, P. E., & Melchers, W. J. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05088-11 · Cited by 230
Camps, S. M. T., Dutilh, B. E., Arendrup, M. C., Rijs, A. J. M. M., Snelders, E., Huynen, M. A., Verweij, P. E., & Melchers, W. J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050034 · Cited by 212
Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2747-2750.2004 · Cited by 210
Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus
Rodriguez-Tudela, J. L., Alcazar-Fuoli, L., Mellado, E., Alastruey-Izquierdo, A., Monzon, A., & Cuenca-Estrella, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00156-08 · Cited by 209
Multi-azole resistance in Aspergillus fumigatus
Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., & Denning, D. W. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.017 · Cited by 203
Chen, J., Li, H., Li, R., Bu, D., & Wan, Z. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh507 · Cited by 198
Chowdhary, A., Kathuria, S., Xu, J., Sharma, C., Sundar, G., Singh, P. K., Gaur, S. N., Hagen, F., Klaassen, C. H., & Meis, J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052871 · Cited by 195
Self-citationBaddley, J. W., Marr, K. A., Andes, D. R., Walsh, T. J., Kauffman, C. A., Kontoyiannis, D. P., Ito, J. I., Balajee, S. A., Pappas, P. G., & Moser, S. A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00854-09 · Cited by 190
Mann, P. A., Parmegiani, R. M., Wei, S.-Q., Mendrick, C. A., Li, X., Loebenberg, D., DiDomenico, B., Hare, R. S., Walker, S. S., & McNicholas, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.577-581.2003 · Cited by 189
Chowdhary, A., Kathuria, S., Randhawa, H. S., Gaur, S. N., Klaassen, C. H., & Meis, J. F. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr443 · Cited by 188
Self-citationEmergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany
Steinmann, J., Hamprecht, A., Vehreschild, M. J. G. T., Cornely, O. A., Buchheidt, D., Spiess, B., Koldehoff, M., Buer, J., Meis, J. F., & Rath, P.-M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku566 · Cited by 185
Self-citationMortensen, K. L., Jensen, R. H., Johansen, H. K., Skov, M., Pressler, T., Howard, S. J., Leatherbarrow, H., Mellado, E., & Arendrup, M. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00213-11 · Cited by 180
Burgel, P.-R., Baixench, M.-T., Amsellem, M., Audureau, E., Chapron, J., Kanaan, R., Honoré, I., Dupouy-Camet, J., Dusser, D., Klaassen, C. H., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05077-11 · Cited by 178
Self-citationWiederhold, N. P., Gil, V. G., Gutierrez, F., Lindner, J. R., Albataineh, M. T., McCarthy, D. I., Sanders, C., Fan, H., Fothergill, A. W., & Sutton, D. A. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02478-15 · Cited by 168
Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole
Ferreira, M. E. D. S., Malavazi, I., Savoldi, M., Brakhage, A. A., Goldman, M. H. S., Kim, H. S., Nierman, W. C., & Goldman, G. H. (2006) · Current Genetics · doi:10.1007/s00294-006-0073-2 · Cited by 160
Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity
Rajendran, R., Mowat, E., McCulloch, E., Lappin, D. F., Jones, B., Lang, S., Majithiya, J. B., Warn, P., Williams, C., & Ramage, G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01189-10 · Cited by 159
Chowdhary, A., Sharma, C., Hagen, F., & Meis, J. F. G. M. (2014) · Future Microbiology · doi:10.2217/fmb.14.27 · Cited by 152
Self-citationAlvarez-Moreno, C., Lavergne, R.-A., Hagen, F., Morio, F., Meis, J. F., & Le Pape, P. (2017) · Scientific Reports · doi:10.1038/srep45631 · Cited by 141
Self-citationVerweij, P. E., Zhang, J., Debets, A. J. M., Meis, J. F., van de Veerdonk, F. L., Schoustra, S. E., Zwaan, B. J., & Melchers, W. J. G. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30138-4 · Cited by 140
Self-citationHodiamont, C. J., Dolman, K. M., ten Berge, I. J. M., Melchers, W. J. G., Verweij, P. E., & Pajkrt, D. (2008) · Medical Mycology · doi:10.1080/13693780802545600 · Cited by 135
Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin
Ong, V. S., Hough, G., Schlosser, M., Bartizal, K. F., Balkovec, J. M., James, K. D., & Krishnan, B. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00701-16 · Cited by 133
Bader, O., Weig, M., Reichard, U., Lugert, R., Kuhns, M., Christner, M., Held, J., Peter, S., Schumacher, U., Buchheidt, D., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00167-13 · Cited by 131
Morio, F., Aubin, G. G., Danner‐Boucher, I., Haloun, A., Sacchetto, É., Garcia‐Hermoso, D., Bretagne, S., Miegeville, M., & Pape, P. L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks160 · Cited by 131
Tobin, M. B., Peery, R., & Skatrud, P. (1997) · Gene · doi:10.1016/s0378-1119(97)00281-3 · Cited by 127
Alanio, A., Sitterlé, E., Liance, M., Farrugia, C., Foulet, F., Botterel, F., Hicheri, Y., Cordonnier, C., Costa, J., & Bretagne, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq450 · Cited by 126
Hsueh, P., Lau, Y.-J., Chuang, Y.-C., Wan, J.-H., Huang, W.-K., Shyr, J.-M., Yan, J.-J., Yu, K.-W., Wu, J.-J., Ko, W., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.512-517.2005 · Cited by 122
Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., & Meis, J. F. G. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00428 · Cited by 121
Self-citationHagiwara, D., Takahashi, H., Watanabe, A., Takahashi‐Nakaguchi, A., Kawamoto, S., Kamei, K., & Gonoi, T. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01105-14 · Cited by 116
High prevalence of azole resistance inAspergillus fumigatusisolates from high-risk patients
Führen, J., Voskuil, W. S., Boel, C. H. E., Haas, P., Hagen, F., Meis, J. F. G. M., & Kusters, J. G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv177 · Cited by 107
Self-citationvan Ingen, J., van der Lee, H. A., Rijs, T. A. J., Zoll, J., Leenstra, T., Melchers, W. J. G., & Verweij, P. E. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku364 · Cited by 106
van Paassen, J., Russcher, A., Wingerden, A. W. M. I. V.-V., Verweij, P. E., & Kuijper, E. J. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.30.30300 · Cited by 106
Environmental Isolates of Azole-Resistant Aspergillus fumigatus in Germany
Bader, O., Tünnermann, J., Dudakova, A., Tangwattanachuleeporn, M., Weig, M., & Groß, U. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00100-15 · Cited by 103
Tashiro, M., Izumikawa, K., Hirano, K., Ide, S., Mihara, T., Hosogaya, N., Takazono, T., Morinaga, Y., Nakamura, S., Kurihara, S., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00514-12 · Cited by 103
Astvad, K. M. T., Jensen, R. H., Hassan, T. M., Mathiasen, E. G., Thomsen, G. M., Pedersen, U. G., CHRISTENSEN, M. B., Hilberg, O., & Arendrup, M. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02855-14 · Cited by 100
Albarrag, A., Anderson, M. J., Howard, S. J., Robson, G., Warn, P. A., Sanglard, D., & Denning, D. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-11 · Cited by 100
Multi‐triazole‐resistant Aspergillus fumigatus infections in Australia
Kidd, S. E., Goeman, E., Meis, J. F. G. M., Slavin, M. A., & Verweij, P. E. (2015) · Mycoses · doi:10.1111/myc.12324 · Cited by 97
Self-citationPassive Surveillance for Azole-ResistantAspergillus fumigatus, United States, 2011–2013
Pham, C. D., Reiss, E., Hagen, F., Meis, J. F. G. M., & Lockhart, S. R. (2014) · Emerging infectious diseases · doi:10.3201/eid2009.140142 · Cited by 96
Self-citationLepak, A. J., Marchillo, K., VanHecker, J., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01355-13 · Cited by 93
Vermeulen, E., Maertens, J. A., Schoemans, H. M., & Lagrou, K. (2012) · Eurosurveillance · doi:10.2807/ese.17.48.20326-en · Cited by 91
Koehler, P., Hamprecht, A., Bader, O., Bekeredjian-Ding, I., Buchheidt, D., Doelken, G., Elias, J., Haase, G., Hahn-Ast, C., Karthaus, M., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.10.019 · Cited by 91
Sharma, C., Hagen, F., Moroti, R., Meis, J. F. G. M., & Chowdhary, A. (2015) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2015.01.005 · Cited by 90
Self-citationIntercountry Transfer of Triazole-Resistant Aspergillus fumigatus on Plant Bulbs
Dunne, K., Hagen, F., Pomeroy, N., Meis, J. F. G. M., & Rogers, T. R. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix257 · Cited by 88
Self-citationIn-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole
Dannaoui, É., Persat, F., Monier, M., Borel, E., Piens, M., & Picot, S. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.4.553 · Cited by 86
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma
Bellete, B., Raberin, H., Morel, J., Flori, P., Hafid, J. E., & Sung, R. T. M. (2009) · Medical Mycology · doi:10.3109/13693780902717018 · Cited by 83
Wei, X., Chen, P., Gao, R., Li, Y., Zhang, A., Liu, F., & Lü, L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-16 · Cited by 76
Lavergne, R., Morio, F., Favennec, L., Dominique, S., Meis, J. F. G. M., Gargala, G., Verweij, P. E., & Pape, P. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00127-15 · Cited by 74
Self-citationPharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
Seyedmousavi, S., Brüggemann, R. J. M., Meis, J. F. G. M., Melchers, W. J. G., Verweij, P. E., & Mouton, J. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04907-14 · Cited by 72
Self-citationGregson, L., Goodwin, J., Johnson, A., McEntee, L., Moore, C. B., Richardson, M. D., Hope, W. W., & Howard, S. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01141-13 · Cited by 72
Paul, S. K., Diekema, D. J., & Moye-Rowley, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02748-16 · Cited by 70
Howard, S. J., Lass‐Flörl, C., Cuenca‐Estrella, M., Gómez‐López, A., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-13 · Cited by 69
Azole‐resistant Aspergillus fumigatus isolates carrying TR 34/L98H mutations in Taiwan
Wu, C., Wang, H., Lee, J., Lo, H., Dai, C.-T., Chou, P., Ko, W., & Chen, Y. (2015) · Mycoses · doi:10.1111/myc.12354 · Cited by 68
Heo, S. T., Tatara, A. M., Jiménez-Ortigosa, C., Jiang, Y., Lewis, R. E., Tarrand, J., Tverdek, F., Albert, N. D., Verweij, P. E., Meis, J. F., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix297 · Cited by 67
Self-citationXiong, Q., Hassan, S. A., Wilson, W. K., Han, X. Y., May, G. S., Tarrand, J. J., & Matsuda, S. P. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.518-524.2005 · Cited by 66
Lavergne, R., Chouaki, T., Hagen, F., Toublanc, B., Dupont, H., Jounieaux, V., Meis, J. F. G. M., Morio, F., & Pape, P. L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw664 · Cited by 66
Self-citationÖzmerdiven, G. E., Aksoy, S. A., Ener, B., Ağca, H., Cılo, B. D., Tunca, B., & Akalın, H. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.04.012 · Cited by 65
Azole-Resistant Aspergillus fumigatus , Iran
Seyedmousavi, S., Hashemi, S. J., Zibafar, E., Zoll, J., Hedayati, M. T., Mouton, J. W., Melchers, W. J. G., & Verweij, P. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1905.130075 · Cited by 64
Escribano, P., Recio, S., Peláez, T., Bouza, E., & Guinea, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01358-10 · Cited by 63
Ahmad, S., Joseph, L., Hagen, F., Meis, J. F. G. M., & Khan, Z. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku410 · Cited by 62
Self-citationJensen, R. H., Hagen, F., Astvad, K. M. T., Tyron, A., Meis, J. F. G. M., & Arendrup, M. C. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.001 · Cited by 61
Self-citationAzole resistance surveillance inAspergillus fumigatus: beneficial or biased?
Verweij, P. E., Lestrade, P. P. A., Melchers, W. J. G., & Meis, J. F. G. M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw259 · Cited by 60
Self-citationPeláez, T., Gijón, P., Bunsow, E., Bouza, E., Sánchez-Yebra, W., Valerio, M., Gama, B., Cuenca‐Estrella, M., & Mellado, E. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00329-12 · Cited by 57
Multiple Fungicide-Driven Alterations in Azole-ResistantAspergillus fumigatus, Colombia, 2015
Pape, P. L., Lavergne, R., Morio, F., & Álvarez, C. (2015) · Emerging infectious diseases · doi:10.3201/eid2201.150978 · Cited by 55
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany
Hamprecht, A. G., Buchheidt, D., Vehreschild, J. J., Cornely, O. A., Spieß, B., Plum, G., Halbsguth, T. V., Kutsch, N., Stippel, D. L., Kahl, P., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.36.20262-en · Cited by 52
Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan
Hagiwara, D., Takahashi, H., Fujimoto, M., Sugahara, M., Misawa, Y., Gonoi, T., Itoyama, S., Watanabe, A., & Kamei, K. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.01.015 · Cited by 51
Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy
Prigitano, A., Esposto, M. C., Biffi, A., Lorenzis, G. D., Favuzzi, V., Koncan, R., Cascio, G. L., Barao, M. O., Colombo, C., Pizzamiglio, G., et al. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2016.06.006 · Cited by 50
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection
Lazzarini, C., Esposto, M. C., Prigitano, A., Cogliati, M., Lorenzis, G. D., & Tortorano, A. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02234-15 · Cited by 45
Choukri, F., Botterel, F., Sitterlé, E., Bassinet, L., Foulet, F., Guillot, J., Costa, J., Fauchet, N., & Dannaoui, É. (2015) · Medical Mycology · doi:10.1093/mmy/myv029 · Cited by 42
First Reported Case of Azole-Resistant Aspergillus fumigatus Due to the TR/L98H Mutation in Germany
Rath, P., Buchheidt, D., Spieß, B., Arfanis, E., Buer, J., & Steinmann, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01017-12 · Cited by 42
Kuipers, S., Brüggemann, R. J. M., de Sévaux, R. G. L., Heesakkers, J. P. F. A., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01544-10 · Cited by 41
Diagnosis and management of aspergillosis in the Netherlands: a national survey
Lestrade, P. P. A., Meis, J. F. G. M., Arends, J. P., van der Beek, M. T., Brauwer, E. D., van Dijk, K., de Greeff, S. C., Haas, P., Hodiamont, C. J., Kuijper, E. J., et al. (2015) · Mycoses · doi:10.1111/myc.12440 · Cited by 41
Self-citationPeláez, T., Monteiro, M. C., Garcia‐Rubio, R., Bouza, E., Gómez‐López, A., & Mellado, E. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.04.005 · Cited by 39
Vázquez, J. A., & Manavathu, E. K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01130-15 · Cited by 36
Lepak, A. J., Marchillo, K., VanHecker, J., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00833-13 · Cited by 35
Toyotome, T., Hagiwara, D., Kida, H., Ogi, T., Watanabe, A., Wada, T., Komatsu, R., & Kamei, K. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.12.004 · Cited by 32
Mohammadi, F., Hashemi, S. J., Zoll, J., Melchers, W. J. G., Rafati, H., Dehghan, P., Rezaie, S., Tolooe, A., Tamaddon, Y., van der Lee, H. A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02326-15 · Cited by 31
Mushi, M. F., Buname, G., Bader, O., Groß, U., & Mshana, S. E. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1796-4 · Cited by 28
Brillowska‐Dąbrowska, A., Mroczyńska, M., Nawrot, U., Włodarczyk, K., & Kurzyk, E. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1143 · Cited by 24
New case of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in Belgium
Montesinos, I., Dodémont, M., Lagrou, K., Jacobs, F., Etienne, I., & Denis, O. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku289 · Cited by 22
Gonçalves, S. S. (2017) · Journal of Fungi · doi:10.3390/jof3010005 · Cited by 22
Asano, M., Kano, R., Kamata, H., Makimura, K., & Hasegawa, A. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0202-1 · Cited by 21
Alanio, A., Denis, B., Hamane, S., Raffoux, E., de Latour, R. P., Touratier, S., Bergeron, A., & Bretagne, S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw036 · Cited by 15
Invasive pulmonary aspergillosis due to a multi-azole resistant Aspergillus fumigatus.
Jeurissen, A., Cooreman, S., Kerckhoven, W. V., Leemput, J. V., Vanhove, P., Lagrou, K., & Heytens, L. (2012) · PubMed · doi:10.2143/acb.67.1.2062627 · Cited by 12
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Antifungal Susceptibility Testing: Current Approaches
Berkow, E. L., Lockhart, S. R., & Ostrosky-Zeichner, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-19 · Cited by 368
Rudramurthy, S. M., Paul, R. A., Chakrabarti, A., Mouton, J. W., & Meis, J. F. (2019) · Journal of Fungi · doi:10.3390/jof5030055 · Cited by 299
Self-citationAntimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications
Talapko, J., Meštrović, T., Juzbašić, M., Tomas, M., Erić, S., Horvat Aleksijević, L., Bekić, S., Schwarz, D., Matić, S., Neuberg, M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101417 · Cited by 281
Pfaller, M. A., Huband, M. D., Flamm, R. K., Bien, P. A., & Castanheira, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00840-19 · Cited by 80
Metadata
- Authors
- Chowdhary, A., Sharma, C., & Meis, J. F.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-15
- Volume
- 216
- Issue
- suppl_3
- Pages
- S436-S444
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2751215887
- Cited by
- 262
- References
- 107
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.